Fomiversen Sodium Approved to Treat CMV Retinitis-Reference-Cited by-同舟云学术

Fomiversen Sodium Approved to Treat CMV Retinitis

Published:1999-01 Issue:1 Volume:39 Page:84-85
ISSN:1086-5802
Container-title:Journal of the American Pharmaceutical Association (1996)
language:en
Short-container-title:Journal of the American Pharmaceutical Association (1996)

Author:

Piascik Peggy

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference4 articles.

1. ARVO presentations show safety and efficacy of Isis' CMV retinitis drug. [press release];Association for Vision Research and Ophthalmology,1997

2. Ocular manifestations of acquired immune deficiency syndrome;Jabs;Ophthalmology.,1989

3. Cytomegalovirus retinitis as the initial manifestation of the acquired immune deficiency syndrome;Henderly;Am J Ophthalmol.,1987

4. Foscarnet-ganciclovir cytomegalovirus retinitis trial: 4. Visual outcomes. Studies of Ocular Complications of AIDS (SOCA) Research Group in collaboration with the AIDS Clinical Trials Group;SOCA;Ophthalmology,1994

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assembling the RNA therapeutics toolbox;Medical Review;2024-03-20

2. RNA therapeutics for disorders of excretory system;Progress in Molecular Biology and Translational Science;2024

3. Nucleic acid-based therapy for brain cancer: Challenges and strategies;Journal of Controlled Release;2022-10

4. The Progress and Promise of RNA Medicine─An Arsenal of Targeted Treatments;Journal of Medicinal Chemistry;2022-05-09

5. Current Advances in RNA Therapeutics for Human Diseases;International Journal of Molecular Sciences;2022-03-01